靶点- |
|
|
|
|
非在研适应症- |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期- |
Ph 1, Open-Label Safety Study of Escalating Doses of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous ADSCs in Participants With Mild-Moderate AD Whose Treatment is Not Addressed Adequately by Available Therapy
This is a research study to evaluate the safety of an investigational autologous cell product obtained from participant's own adipose tissue as a possible treatment for Alzheimer disease.
100 项与 Regeneration Biomedical, Inc. 相关的临床结果
0 项与 Regeneration Biomedical, Inc. 相关的专利(医药)
100 项与 Regeneration Biomedical, Inc. 相关的药物交易
100 项与 Regeneration Biomedical, Inc. 相关的转化医学